WallStSmart
DTIL

Precision BioSciences Inc

NASDAQ: DTIL · HEALTHCARE · BIOTECHNOLOGY

$7.15
+3.62% today

Updated 2026-04-30

Market cap
$181.66M
P/E ratio
P/S ratio
5.30x
EPS (TTM)
$-3.63
Dividend yield
52W range
$4 – $9
Volume
0.3M

Precision BioSciences Inc (DTIL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$7.01M$6.48M$10.88M$22.24M$24.29M$115.53M$25.10M$48.73M$68.70M$34.26M
Revenue growth (YoY)-7.6%+67.8%+104.3%+9.2%+375.7%-78.3%+94.1%+41.0%-50.1%
Cost of revenue$0.00$0.00$0.00$9.00M$8.26M$4.58M$2.75M
Gross profit$7.01M$6.48M$10.88M$22.24M$24.29M$115.53M$25.10M$48.73M$68.70M$31.51M
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%92.0%
R&D$9.10M$20.32M$45.12M$82.42M$98.06M$115.24M$46.12M$53.38M$59.56M$54.17M
SG&A$6.17M$8.02M$13.67M$27.03M$36.05M$39.67M$41.28M$39.09M$35.30M$32.24M
Operating income$-8.83M$-21.97M$-47.91M$-87.20M$-109.83M$-39.38M$-62.31M$-43.74M$-26.16M$-52.15M
Operating margin-125.8%-338.9%-440.2%-392.1%-452.2%-34.1%-248.3%-89.8%-38.1%-152.2%
EBITDA$-8.19M$-20.42M$-43.68M$-87.38M$-99.19M$-20.27M$-62.79M$-32.04M$13.53M$-49.40M
EBITDA margin-116.7%-314.9%-401.4%-392.9%-408.5%-17.5%-250.2%-65.8%19.7%-144.2%
EBIT$-8.83M$-21.86M$-46.04M$-92.69M$-109.01M$-30.47M$-71.80M$-40.30M$8.95M$-52.15M
Interest expense$0.00$0.00$0.00$182000.00$822000.00$132000.00$1.11M$2.23M$1.78M$1.42M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-8.25M$-21.10M$-46.04M$-92.88M$-109.01M$-30.60M$-111.64M$-61.32M$7.17M$-46.61M
Net income growth (YoY)-155.8%-118.2%-101.7%-17.4%+71.9%-264.8%+45.1%+111.7%-750.3%
Profit margin-117.6%-325.4%-423.0%-417.6%-448.9%-26.5%-444.8%-125.8%10.4%-136.0%